[HTML][HTML] Primary sclerosing cholangitis–a comprehensive review

TH Karlsen, T Folseraas, D Thorburn, M Vesterhus - Journal of hepatology, 2017 - Elsevier
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct
strictures and progressive liver disease. Inflammatory bowel disease is usually present and …

Primary sclerosing cholangitis

JK Dyson, U Beuers, DEJ Jones, AW Lohse, M Hudson - The Lancet, 2018 - thelancet.com
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by
intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and …

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

A Berzigotti, E Tsochatzis, J Boursier, L Castera… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

EASL Clinical Practice Guidelines on sclerosing cholangitis

O Chazouilleres, U Beuers, A Bergquist, TH Karlsen… - Journal of …, 2022 - Elsevier
Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

CL Bowlus, L Arrivé, A Bergquist, M Deneau… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

Quantitative elastography methods in liver disease: current evidence and future directions

P Kennedy, M Wagner, L Castéra, CW Hong… - Radiology, 2018 - pubs.rsna.org
Chronic liver diseases often result in the development of liver fibrosis and ultimately,
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …

Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers

U Agbim, SK Asrani - Expert review of gastroenterology & …, 2019 - Taylor & Francis
Introduction: Non-invasive assessment of fibrosis is increasingly utilized in clinical practice
to diagnose hepatic fibrosis. Non-invasive assessment of liver fibrosis relies on biologic …

Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

A Duarte-Rojo, B Taouli, DH Leung, D Levine… - Hepatology, 2025 - journals.lww.com
Conclusions: LSM from TE, shear wave elastography, and MRE shows acceptable to
outstanding accuracy for the detection of liver fibrosis across various liver disease etiologies …

[PDF][PDF] Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning

JE Eaton, M Vesterhus, BM McCauley… - …, 2020 - Wiley Online Library
Improved methods are needed to risk stratify and predict outcomes in patients with primary
sclerosing cholangitis (PSC). Therefore, we sought to derive and validate a prediction model …

Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process

CY Ponsioen, DN Assis, KM Boberg, CL Bowlus… - …, 2021 - gastrojournal.org
Although patients with PSC are increasingly diagnosed at earlier stages of disease based
on asymptomatic serum liver enzyme abnormalities, at least 45% of patients PSC present …